In 1911, Dr. Mendel Nevin founded Novocol Chemical Manufacturing Company, Inc. The Company imported “PROCAINE” into the United States from Germany. The success of this product was so profound that Dr. Nevin curtailed his private dental practice and devoted his full time to manufacturing Procaine in the United States.
The U.S. Government granted the first license to synthesize and manufacture Procaine when the United States entered World War I. In 1926 the Company expanded into Canada and opened its second manufacturing facility in Toronto. The Canadian plant filled dental anaesthetic in glass cartridges.
During World War II, Novocol was the only manufacturer of anaesthetics to receive the U.S. Army and Navy “E” Award for excellence and service to the military. A number of other firsts were attributed to Novocol, including the introduction of the metal capped cartridge and the vacuum packed can.
The present Canadian facility was completed in Cambridge in 1979. In 1983, the U.S. manufacturing facility merged with the Canadian plant. The current facility has been upgraded several times with another major expansion completed in the 2nd quarter of 2012.
The future represents challenging opportunities for Novocol. The work done here benefits the health care of dental patients throughout the world.
By seeking to offer the most complete line of high quality and low cost dental anaesthetic & therapeutic products to the international dental community, Novocol ensures security for our Novocol family partners. Working together we have unique & mutually rewarding growth opportunities.
*Photo Credit: Journal of the American Dental Society of Anesthesiology, 1959 April; 6(4): 8–9 (Online)